Screener
National Health Investors NHI Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenue.
The source filing: National Health Investors’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000135
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Debt, net | $1,269,668 | $1,163,814 |
| Accounts payable and other liabilities | 37,846 | 43,734 |
| Dividends payable | 44,610 | 44,439 |
| Deferred income | 5,207 | 4,996 |
| Total liabilities1 | 1,357,331 | 1,256,983 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 9,922 | 10,195 |
| Equity: |
Item 1. Financial Statements
FAQ
- What is National Health Investors's deferred revenue?
- National Health Investors (NHI) reported deferred revenue of $5.21M in Q1 2026.
- How has National Health Investors's deferred revenue changed year-over-year?
- National Health Investors's deferred revenue increased by 26.9% year-over-year, from $4.1M to $5.21M.
- What is the long-term trend for National Health Investors's deferred revenue?
- Over 5 years (2020 to 2025), National Health Investors's deferred revenue has grown at a -16.9% compound annual growth rate (CAGR), from $12.61M to $5M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about National Health Investors's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude